Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Atome losses widen in first half

(Sharecast News) - Atome reported a wider first-half loss on Friday, but said it had made "considerable progress" on its flagship Villeta low-carbon fertiliser project as it moved towards a final investment decision before the end of 2025. For the six months ended 30 June, the AIM-traded company posted a loss of $3.1m, compared with $2.8m a year earlier, with $6.6m of costs capitalised on the 145MW Villeta project.

Operationally, the period saw Hy24 agree to invest $115m as lead equity investor, while Atome signed a $465m fixed-price EPC contract with Casale and began detailed engineering work.

A new Atome Power division was also created to advance plans for a 400MW solar facility in Paraguay.

Post-period, the European Investment Bank gave in-principle approval for $135m of senior debt financing, while the Green Climate Fund agreed to provide $50m of concessional finance.

Final agreements with offtaker Yara and equity investors were expected in September, paving the way for a final investment decision and construction start by year-end.

"The Villeta project is expected be the largest low-carbon fertiliser production facility in the world when it comes on stream," said chief executive Olivier Mussat.

"With news of signing the definitive offtake agreement with Yara, constitution of the project equity club and of the multilateral lenders in the Project Financing expected in the coming weeks, we will then be well set to navigate our course for FID and commencement of construction by the end of the year."

He added that Atome was "uniquely positioned to expand its platform" once construction begins, supported by its project pipeline, government backing in Paraguay and growing financing commitments.

At 1211 BST, shares in Atome were up 9.38% at 49.22p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.